UroGen Pharma Ltd. (LON:0XOD)
London flag London · Delayed Price · Currency is GBP · Price in USD
18.80
+0.30 (1.60%)
At close: Sep 5, 2025

UroGen Pharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
732359363170157292
Upgrade
Market Cap Growth
-3.89%-1.24%113.84%7.95%-46.00%-44.84%
Upgrade
Enterprise Value
70725432115277202
Upgrade
Last Close Price
14.628.6311.666.737.0218.69
Upgrade
PS Ratio
10.644.975.603.184.4433.74
Upgrade
PB Ratio
-10.74-51.05-7.10-2.2925.344.13
Upgrade
P/TBV Ratio
----25.344.13
Upgrade
EV/Sales Ratio
10.153.524.952.852.1823.36
Upgrade
Debt / Equity Ratio
-1.36-14.19-1.54-1.120.180.03
Upgrade
Asset Turnover
0.380.390.530.500.400.07
Upgrade
Inventory Turnover
1.481.191.871.671.52-
Upgrade
Quick Ratio
3.715.594.884.714.515.09
Upgrade
Current Ratio
4.146.015.425.395.115.39
Upgrade
Return on Equity (ROE)
-----211.55%-92.88%
Upgrade
Return on Assets (ROA)
-31.20%-25.77%-26.10%-38.69%-47.72%-46.29%
Upgrade
Return on Capital (ROIC)
-93.66%-79.15%-179.24%-479.55%-105.88%-52.96%
Upgrade
Earnings Yield
-15.46%-28.23%-22.08%-53.60%-51.98%-32.27%
Upgrade
FCF Yield
-12.32%-21.60%-16.54%-42.88%-40.17%-26.90%
Upgrade
Buyback Yield / Dilution
-29.37%-48.70%-26.43%-2.05%-2.60%-6.10%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.